Literature DB >> 22478944

Does prolonged infusion allow lower daily dose of meropenem than bolus dosing?

Eric Poulin1, Glen Brown.   

Abstract

Entities:  

Year:  2009        PMID： 22478944      PMCID： PMC2827027          DOI： 10.4212/cjhp.v62i6.856

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  7 in total

1.  Use of Monte Carlo simulation to design an optimized pharmacodynamic dosing strategy for meropenem.

Authors:  Joseph L Kuti; Prachi K Dandekar; Charles H Nightingale; David P Nicolau
Journal:  J Clin Pharmacol       Date:  2003-10       Impact factor: 3.126

2.  Prevention of resistance: a goal for dose selection for antimicrobial agents.

Authors:  G L Drusano
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

3.  Pharmacodynamic evaluation of extending the administration time of meropenem using a Monte Carlo simulation.

Authors:  Ben M Lomaestro; G L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.

Authors:  Paul G Ambrose; Sujata M Bhavnani; Christopher M Rubino; Arnold Louie; Tawanda Gumbo; Alan Forrest; George L Drusano
Journal:  Clin Infect Dis       Date:  2006-11-27       Impact factor: 9.079

5.  Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapy.

Authors:  L Santos Filho; K J Eagye; J L Kuti; D P Nicolau
Journal:  Clin Microbiol Infect       Date:  2007-02-28       Impact factor: 8.067

Review 6.  Pharmacokinetic and pharmacodynamic properties of meropenem.

Authors:  David P Nicolau
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

7.  [Clinical efficacy of prolonged (4 hour) drip infusion of meropenem against severe pneumonia].

Authors:  Shigeru Itabashi
Journal:  Jpn J Antibiot       Date:  2007-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.